HEADLINE STOCKS-Some U.S. stocks on the move on Sept. 30

(Updates to add Hospira/Teva, ImmuCell, Orexigen, Omnova)

NEW YORK, Sept 30 (Reuters) - Some U.S. stocks on the move on Wednesday:

CIT GROUP INC CIT.N, $1.38, down 37 pct

The lender to small and medium-sized businesses is nearing a plan that would likely hand the company over to its bondholders, sources familiar with the matter said.

BANK OF AMERICA CORP (BAC.N), $16.99, down 0.9 pct

AMERIPRISE FINANCIAL INC (AMP.N), $36.93, up 14 pct

BofA plans to sell a long-term asset management business to Ameriprise for about $1 billion. [ID:nN30194010]

IMMUCELL CORP (ICCC.O), $3.81, up 34 pct

The company said its experimental drug to treat subclinical mastitis met the main goal of an effectiveness study. [ID:nBNG546218]

HOSPIRA INC (HSP.N), $44.44, down 0.9 pct

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA.O), $50.60, down 1.2 pct

Hospira acquired worldwide rights to a generic version of the white blood-cell boosting drug filgrastim from Teva for an undisclosed amount. [ID:nN30200162]

OREXIGEN THERAPEUTICS INC (OREX.O), $9.98, up 1.5 pct

The company said a mid-stage trial of Empatic, the second obesity drug being developed by the company, met its main goal of demonstrating significant weight loss. [ID:nN30215598]

OMNOVA SOLUTIONS INC (OMN.N), $6.30, up 24 pct

The company late Tuesday posted a better-than-expected third-quarter profit helped by lower raw material costs and said it expects significantly improved earnings in the fourth quarter. [ID:nBNG530564]